The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow's Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study

Bożena Cukrowska, Aldona Ceregra, Elżbieta Maciorkowska, Barbara Surowska, Maria Agnieszka Zegadło-Mylik, Ewa Konopka, Ilona Trojanowska, Magdalena Zakrzewska, Joanna Beata Bierła, Mateusz Zakrzewski, Ewelina Kanarek, Ilona Motyl, Bożena Cukrowska, Aldona Ceregra, Elżbieta Maciorkowska, Barbara Surowska, Maria Agnieszka Zegadło-Mylik, Ewa Konopka, Ilona Trojanowska, Magdalena Zakrzewska, Joanna Beata Bierła, Mateusz Zakrzewski, Ewelina Kanarek, Ilona Motyl

Abstract

Probiotics seem to have promising effects in the prevention and treatment of allergic conditions including atopic dermatitis (AD) and food allergy. The purpose of this multicenter randomized placebo-controlled trial was to evaluate the effectiveness of a probiotic preparation comprising Lactobacillus rhamnosus ŁOCK 0900, Lactobacillus rhamnosus ŁOCK 0908, and Lactobacillus casei ŁOCK 0918 in children under 2 years of age with AD and a cow's milk protein (CMP) allergy. The study enrolled 151 children, who-apart from being treated with a CMP elimination diet-were randomized to receive the probiotic preparation at a daily dose of 109 bacteria or a placebo for three months, with a subsequent nine-month follow-up. The primary outcomes included changes in AD symptom severity assessed with the scoring AD (SCORAD) index and in the proportion of children with symptom improvement (a SCORAD score decreased by at least 30% in comparison with that at baseline). After the three-month intervention, both the probiotic and placebo groups showed a significant (p < 0.0001) decrease in SCORAD scores, which was maintained nine months later. The percentage of children who showed improvement was significantly higher in the probiotic than in the placebo group (odds ratio (OR) 2.56; 95% confidence interval (CI) 1.13-5.8; p = 0.012) after three months. Probiotics induced SCORAD improvement mainly in allergen sensitized patients (OR 6.03; 95% CI 1.85-19.67, p = 0.001), but this positive effect was not observed after nine months. The results showed that the mixture of probiotic ŁOCK strains offers benefits for children with AD and CMP allergy. Further research is necessary to assess the effect of probiotic supplementation on the development of immune tolerance (NCT04738565).

Keywords: Lactobacillus casei; Lactobacillus rhamnosus; atopic dermatitis; cow’s milk protein allergy; food allergy; probiotics.

Conflict of interest statement

B.C. has served as a speaker for Nutricia, Danone, Bayer, Apotex, Polpharma, Biomed S.A., and Mead Johnson. Other authors did not declare the conflict of interest.

Figures

Figure 1
Figure 1
Study protocol flowchart.

References

    1. Tracy A., Bhatti S., Eichenfield L.F. Update on pediatric atopic dermatitis. Cutis. 2020;106:143–146. doi: 10.12788/cutis.0077.
    1. Dattola A., Bennardo L., Silvestri M., Nisticò S.P. What’s new in the treatment of atopic dermatitis? Dermatol. Ther. 2019;32:e12787. doi: 10.1111/dth.12787.
    1. Ratchataswan T., Banzon T.M., Thyssen J.P., Weidinger S., Guttman-Yassky E., Phipatanakul W. Biologics for treatment of atopic dermatitis: Current status and future prospect. J. Allergy Clin. Immunol. Pract. 2021;9:1053–1065. doi: 10.1016/j.jaip.2020.11.034.
    1. Nutten S. Atopic dermatitis: Global epidemiology and risk factors. Ann. Nutr. Metab. 2015;66:8–16. doi: 10.1159/000370220.
    1. Matsumoto K., Iikura K., Morita H., Saito H. Barrier dysfunction in the atopic march-how does atopic dermatitis lead to asthma in children? J. Allergy Clin. Immunol. 2020;145:1551–1553. doi: 10.1016/j.jaci.2020.04.014.
    1. Bantz S.K., Zhu Z., Zheng T. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell. Immunol. 2014;5:202. doi: 10.4172/2155-9899.1000202.
    1. Garcia C., El-Qutob D., Martorell A., Febrer I., Rodriguez M., Cedra J.C., Felix R. Sensitization in early age to food allergens in children with atopic dermatitis. Allergol. Immunopathol. 2007;35:15–20. doi: 10.1157/13099090.
    1. Bergmann M.M., Caubet J.C., Boguniewicz M., Eigenmann P.A. Evaluation of food allergy in patients with atopic dermatitis. J. Allergy Clin. Immunol. Pract. 2013;1:22–28. doi: 10.1016/j.jaip.2012.11.005.
    1. Cukrowska B. Microbial and Nutritional Programming-The Importance of the Microbiome and Early Exposure to Potential Food Allergens in the Development of Allergies. Nutrients. 2018;10:1541. doi: 10.3390/nu10101541.
    1. Abrahamsson T.R., Jakobsson H.E., Andersson A.F., Björkstén B., Engstrand L., Jenmalm M.C. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 2012;129:434–440.e1–2. doi: 10.1016/j.jaci.2011.10.025.
    1. Penders J., Gerhold K., Stobberingh E.E., Thijs C., Zimmermann K., Lau S., Hamelmann E. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J. Allergy Clin. Immunol. 2013;132:601–607.e8. doi: 10.1016/j.jaci.2013.05.043.
    1. Berin M.C. Dysbiosis in food allergy and implications for microbial therapeutics. J. Clin. Investig. 2021;131:e144994. doi: 10.1172/JCI144994.
    1. Fiocchi A., Pawankar R., Cuello-Garcia C., Ahn K., Al-Hammadi S., Agarwal A., Beyer K., Burks W., Canonica G.W., Ebisawa M., et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organ. J. 2015;8:4. doi: 10.1186/s40413-015-0055-2.
    1. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. doi: 10.1038/nrgastro.2014.66.
    1. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy. 2005;60:494–500. doi: 10.1111/j.1398-9995.2004.00514.x.
    1. Grüber C., Wendt M., Sulser C., Lau S., Kulig M., Wahn U., Werfel T., Niggemann B. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy. 2007;62:1270–1276. doi: 10.1111/j.1398-9995.2007.01543.x.
    1. Fölster-Holst R., Müller F., Schnopp N., Abeck D., Kreiselmaier I., Lenz T., von Rüden U., Schrezenmeir J., Christophers E., Weichenthal M. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br. J. Dermatol. 2006;155:1256–1261. doi: 10.1111/j.1365-2133.2006.07558.x.
    1. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., van der Heide S., Jansen D.F., Hoijer M.A., Kauffman H.F., Duiverman E.J. No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trial. Clin. Exp. Allerg. 2006;36:899–906. doi: 10.1111/j.1365-2222.2006.02513.x.
    1. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet. 2001;357:1076–1079. doi: 10.1016/S0140-6736(00)04259-8.
    1. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–1871. doi: 10.1016/S0140-6736(03)13490-3.
    1. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007;119:1019–1021. doi: 10.1016/j.jaci.2006.12.608.
    1. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatric. 2008;121:e850-6. doi: 10.1542/peds.2007-1492.
    1. Cukrowska B., Motyl I., Kozáková H., Schwarzer M., Górecki R.K., Klewicka E., Slizewska K., Libudzisz Z. Probiotic Lactobacillus strains: In vitro and in vivo studies. Folia Microbiol. 2009;54:533–537. doi: 10.1007/s12223-009-0077-7.
    1. Cukrowska B., Rosiak I., Klewicka E., Motyl I., Schwarzer M., Libudzisz Z., Kozakova H. Impact of heat-inactivated Lactobacillus casei and Lactobacillus paracasei strains on cytokine responses in whole blood cell cultures of children with atopic dermatitis. Folia Microbiol. 2010;55:277–280. doi: 10.1007/s12223-010-0041-6.
    1. Oranje A.P., Glazenburg E.J., Wolkerstorfer A., de Waard-van der Spek F.B. Practical issues on interpretation of scoring atopic dermatitis: The SCORAD index, objective SCORAD and the three-item severity score. Br. J. Dermatol. 2007;157:645–648. doi: 10.1111/j.1365-2133.2007.08112.x.
    1. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. 1980;92:44–47.
    1. Aleksandrzak-Piekarczyk T., Koryszewska-Bagińska A., Grynberg M., Nowak A., Cukrowska B., Kozakova H., Bardowski J. Genomic and Functional Characterization of the Unusual pLOCK 0919 Plasmid Harboring the spaCBA Pili Cluster in Lactobacillus casei LOCK 0919. Genome Biol. Evol. 2015;8:202–217. doi: 10.1093/gbe/evv247.
    1. Koryszewska-Baginska A., Aleksandrzak-Piekarczyk T., Bardowski J. Complete Genome Sequence of the Probiotic Strain Lactobacillus casei (Formerly Lactobacillus paracasei) LOCK919. Genome Announc. 2013;1:e00758-13. doi: 10.1128/genomeA.00758-13.
    1. Koryszewska-Baginska A., Bardowski J., Aleksandrzak-Piekarczyk T. Genome Sequence of the Probiotic Strain Lactobacillus rhamnosus (Formerly Lactobacillus casei) LOCK908. Genome Announc. 2014;2:e00120-14. doi: 10.1128/genomeA.00120-14.
    1. Konopka E., Ceregra A., Maciorkowska E., Surowska B., Trojanowska I., Roszko-Kirpsza I., Cukrowska B. Specific IgE Antibodies in Young Children with Atopic Dermatitis—Correlation of Multiple Allergen Simultaneous Immunoblot Test and ImmunoCap System. Clin. Lab. 2016;62:815–821. doi: 10.7754/Clin.Lab.2015.150816.
    1. Cukrowska B., Ceregra A., Rosiak I., Klewicka E., Slizewska K., Motyl I. The influence of probiotic Lactobacillus casei and paracasei strains on clinical status of atopic eczema in children with food allergy on cow’s milk proteins [Wpływ probiotycznych szczepów Lactobacillus casei i paracasei na przebieg kliniczny wyprysku atopowego u dzieci z alergią pokarmową na białka mleka krowiego] Pediatr. Wspolczesna. 2008;10:67–70.
    1. Cukrowska B., Ceregra A., Klewicka E., Slizewska K., Motyl I., Libudzisz Z. Probiotic lactobacillus casei and lactobacillus paracasei strains in treatment of food allergy in children [Probiotyczne szczepy lactobacillus casei i lactobacillus paracasei w leczeniu alergii pokarmowej u dzieci] Przegląd Pediatryczny. 2010;40:21–25.
    1. Makrgeorgou A., Leonardi-Bee J., Bath-Hextall F.J., Murrell D.F., Tang M.L., Roberts A., Boyle R.J. Probiotics for treating eczema. Cochrane Database Syst. Rev. 2018;2018:CD006135. doi: 10.1002/14651858.CD006135.pub3.
    1. Jiang W., Ni B., Liu Z., Liu X., Xie W., Wu I.X.Y., Li X. The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Paediatr. Drugs. 2020;22:535–549. doi: 10.1007/s40272-020-00410-6.
    1. Zhao M., Shen C., Ma L. Treatment efficacy of probiotics on atopic dermatitis, zooming in on infants: A systematic review and meta-analysis. Int. J. Dermatol. 2018;57:635–641. doi: 10.1111/ijd.13873.
    1. Śliżewska K., Motyl I., Klewicka E., Cukrowska B., Libudzisz Z. Effects of probiotic preparation on metabolic activity of enteric microbiota in children with atopic dermatitis. Biotechnol. Biotechnol. Equip. 2009;23:885–887. doi: 10.1080/13102818.2009.10818564.
    1. Ahn S.H., Yoon W., Lee S.Y., Shin H.S., Lim M.Y., Nam Y.D., Yoo Y. Effects of Lactobacillus pentosus in Children with Allergen-Sensitized Atopic Dermatitis. J. Korean Med. Sci. 2020;35:e128. doi: 10.3346/jkms.2020.35.e128.
    1. Navarro-López V., Ramírez-Boscá A., Ramón-Vidal D., Ruzafa-Costas B., Genovés-Martínez S., Chenoll-Cuadros E., Carrión-Gutiérrez M., Horga de la Parte J., Prieto-Merino D., Codoñer-Cortés F.M. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients with Moderate Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2018;154:37–43. doi: 10.1001/jamadermatol.2017.3647.
    1. Czarnowicki T., He H., Krueger J.G., Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics. J. Allergy Clin. Immunol. 2019;143:1–11. doi: 10.1016/j.jaci.2018.10.032.
    1. Carlsten C., Dimich-Ward H., Ferguson A., Watson W., Rousseau R., Dybuncio A., Becker A., Chan-Yeung M. Atopic dermatitis in a high-risk cohort: Natural history, associated allergic outcomes, and risk factors. Ann. Allergy Asthma. Immunol. 2013;110:18–24. doi: 10.1016/j.anai.2012.10.005.
    1. van der Hulst A.E., Klip H., Brand P.L. Risk of developing asthma in young children with atopic eczema: A systematic review. J. Allergy Clin. Immunol. 2007;120:565–569. doi: 10.1016/j.jaci.2007.05.042.
    1. Tsakok T. Does atopic dermatitis cause food allergy? A systematic review. J. Allergy Clin. Immunol. 2016;137:1071–1078. doi: 10.1016/j.jaci.2015.10.049.
    1. Gabet S., Rancière F., Just J., de Blic J., Lezmi G., Amat F., Seta N., Momas I. Asthma and allergic rhinitis risk depends on house dust mite specific IgE levels in PARIS birth cohort children. World Allergy Organ. J. 2019;12:100057. doi: 10.1016/j.waojou.2019.100057.
    1. Elazab N., Mendy A., Gasana J., Vieira E.R., Quizon A., Forno E. Probiotic administration in early life, atopy, and asthma: A meta-analysis of clinical trials. Pediatrics. 2013;132:e666–e676. doi: 10.1542/peds.2013-0246.
    1. van der Aa L.B., Heymans H.S., van Aalderen W.M., Sillevis Smitt J.H., Knol J., Ben Amor K., Goossens D.A., Sprikkelman A.B., Synbad Study Group Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Clin. Exp. Allergy. 2010;40:795–804. doi: 10.1111/j.1365-2222.2010.03465.x.
    1. van der Aa L.B., van Aalderen W.M., Heymans H.S., Henk Sillevis Smitt J., Nauta A.J., Knippels L.M., Ben Amor K., Sprikkelman A.B., Synbad Study Group Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy. 2011;66:170–177. doi: 10.1111/j.1398-9995.2010.02416.x.
    1. Canani B.R., Di Costanzo M., Bedogni G., Amoroso A., Cosenza L., Di Scala C., Granata V., Nocerino R. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow’s milk allergy: 3-year randomized controlled trial. J. Allergy Clin. Immunol. 2017;139:1906–1913.e4. doi: 10.1016/j.jaci.2016.10.050.
    1. Kozakova H., Schwarzer M., Tuckova L., Srutkova D., Czarnowska E., Rosiak I., Hudcovic T., Schabussova I., Hermanova P., Zakostelska Z., et al. Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell. Mol. Immunol. 2016;13:251–262. doi: 10.1038/cmi.2015.09.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe